Plunkett Research Online: Odonate Therapeutics

ODONATE THERAPEUTICS (ODT) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Odonate Therapeutics Inc is a US-based pharmaceutical company that is engaged in the development of therapeutics which improves and extends the lives of patients with cancer. The company mainly focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs, taxa.....


ODONATE THERAPEUTICS

Ticker: ODT
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 858 731-8180
Fax:
Address: 4747 Executive Drive
San Diego, CA 92121 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Kevin TangCEO/Chairman of the Board/Director
Michael HearneCFO/Chief Accounting Officer
See More
Odonate Therapeutics Inc is a US-based pharmaceutical company that is engaged in the development of therapeutics which improves and extends the lives of patients with cancer. The company mainly focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs, taxa.....See More See More

$USD, In whole numbers2020201920182017201620152014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture